. Human peripheral blood T cells were stimulated to proliferate when cultured with submitogenic doses of phorbol myristate acetate (PtW) and goat antibodies to ecto-5'-nucleotidase (ecto-5'-NT) .
The degree of proliferation, as measured by 3~-thpidine incorporation on day 3, was similar to that achieved by stimulation with phytohemagglutinin (PHA). Anti-5'-NT antibodies had no effect on PtA-induced proliferation. tlaximal stimulation was achieved wit11 0.6-1.0 ng PMA/ml and 150 !Jg/ml of IgG isolated from a goat anti-5'-NT antiserum. Both intact IgG and F(ab1)2 fragments were stimulatory. IL-2 receptor expression and IL-2 secretion were also induced by anti-5'-NT antibodies and PIN. As expected, anti-5'-NT antibodies and PMA did not induce the proliferation of ecto-5'-NT-T cells isolated by cell sorting. Pretreatment of total T cells with phosphatidylinositol (PI)-specific phospholipase C removed 80% of the ecto-5'-NT activity from the cell surface and also inhibited the ability of the cells to proliferate in response to anti-5'-NT antibodies and PMA by 84%. Thus, the activation signal provided by anti-ecto-5'-NT antibodies is apparently transduced by a form of the enzyme which is attached to the membrane via PI-linkage. These data suggest that ecto-5'-NT may play a role in lymphocyte activation as has been proposed for other PI-linked lymphocyte surface proteins including Thy-1, T cell activating protein, TAP, and the rat alloantigen XT-6.
PU;IIIJS NUCLZOTIDES SYlJTHESIS DURING TERi-IINAL
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DIFTERNTIATION
Hiroshi Tsutani, Teruo Yoshimura, 14ichihilo UchiZa, Xenichi icamiya, Takanori Ueda, T o m Nakamura The 1st Department of Internal i,ieSricine, F W u i iqedical Schml, Xatsuoka, W u i , J a p n Changes of PRPP-related enzyme activities and incorporation rates of glycine, Hx and Ad into acid soluble fraction (ASP) of HL60 cells were studied during terminal differentiation induced by incubation with 1.6% DMSO for 43 hours. Activities of HPRT, APRT, and PRPP synthetase were determined in homgienate treated with activated chacoal. H(A)PRT activ ies were measured based on the determination of conversion of "C-lakeled k" ( M ) to IMP IAhP). PRPP synthetase activities were measured as follows; PIRPP, which was formed by interaction of R-5-P, ATP and enzyme solution, was measured by HPRT assay system. Incorporation rates of Ad, Hx, and glycine into purine nucleotides were measured after incub ion at 37'C for 20 min in the presence of the respective "C-labeled compound in HA01 medium. W s of cell pelletes, which were obtained by silicon oil procedure, were chromatographed. 2adioactivities of all purine nucleotides were counted. HPRT and RT activities increased 3.3 folds (4.69 to Transport and intracellular metabolism of the three fluorinated pyrimidines, FU, FUR and FUdR in normal human RBCs, L-1210, HL-60, CCRF-CEM and Hela cells were studied. The cells were suspended in HE 101 medium and incubated at 37"C in the presence of each labelled compound. At the desingated time, the cell suspension was put onto silicone oil layer (specific gravity:1.034) and centrifuged at 12,000~9 in 7 sec. The radioactivity of cell pellet obtained was counted following lysis with NCS tissue solubilyzer. The acid-soluble fraction from cell pellet was applied onto silica gel TLC plate and chromatographed. The plate was cut into 0.5cm strips and their radioactivities were counted. All three compounds showed the same velocity of transport by RBCs. FUR transport velocity was, however, markedly high in case of L-1210, HL-60, CCRF-CEM cells and not in Hela cells.
FU and FUdR transports remained at low level.
These results showed that intracellular phosphorylation of the compound resulted in the aculnulation in cell s since FUR was preferentially converted to nucleotide form, while FU and FUdR were not in all cells studied. The chromatogram of FUdR treated CCRF-CEM and Hela cells revealed that the main radioactive peak coinsided with FU.
It was concluded that FUR acumulated as its nucleotide form, while
FUdR was mainly converted to FU in these cells.
BIOCHEMICAL GENETIC ANALYSIS OF NUCLEOSIDE TRANSPORT IN LEISHMANIA DONOVAN1 PROMASTIGOTES
164 ~uddy UI !man,
The Oreqon Health Sciences University. ~e~artment of Biochemistry, port land; .Oregon, U.S.A. A rapid sampling kinetic technique has been used to evaluate the nucleoside transport functions of Leishmania donovani. The results indicate that Leishmania donovani promastigotespossess two independent purine n u c l e o s i d e m r t e r s of broad but non overlapping substrate specificity. The first transports inosine, guanosine and their analogs, while the second recognizes adenosine, analogs of adenosine, and the pyrimidine nucleosides, uridine, cytidine, and thymidine. Mutant strains of Leishmania have been generated that are genetically deficient in their expression of either of the two nucleoside transport systems. The apparent K values of the two nucleoside permeases for their purTne nucleoside substrates were 0.3 -0.6 micromolar, approximately two orders of magnitude lower than the Km values of the mammalian nucleoside transporter for these nucleosides. Wild type Leishmania were capable of concentrating purine nucleosides from the medium and converting them to the nucleotide level with great efficiency and rapidity. lnosine and adenosine transport could be distinguished by different sensitivities to sulphydryl reagents suggesting structural differences betweon the two carriers. Both nucleoside transporters were virtually refractory to inh I ..I t ion by NBIdPR and DPA, two potent inhibitors of nucleoside entry into mammalian cells. This latter observation has important chemotherapeutic implications for the treatment of diseases of parasitic origin.
GENETIC ANALYSIS OF 2',3'-DIDEOXYCYTIDINE METABOLISM IN HUMAN CEM T LYMPHOBLASTS
165 Buddy Ul !man,
The Oregon Health Sciences University, Biochemistry Department, Portland, Oregon, U.S.A. 2',3'-Dideoxycytidine (ddC) is known to inhibit the in vitro infectivity and growth of HTLV-III/LAV, the causative agent of acquired immunodeficiency syndromo (AIDS). The cellular determinants that mediate the action of ddC in cultured human CEM thymic lymphoblasts were analyzed by somatic cell genetic approaches. Whereas ddC at a concentration of 5 micromolar inhibited the growth of wi Id type CEM cel Is by 50%, two nucleoside transport-deficient clones were 4-fold resistant to the pyrimidine analog. A deoxycytidine kinase-deficient CEI4 cell derivative was completely refractory to growth inhibition by 1 millimolar ddC. An 80% diminished rate of ddC influx into the two nucleoside transport-deficient cell lines could account for their resistance to the dideoxynucleoside, while the resistancc of the deoxycytidine kinase-deficient cells to ddC toxicity could be explained by a complete failure to incorporate ddC in situ. NBMPR and DPA, two potent inhibitors of nucleoside transport in mammalian cells, mimicked the effects of the genetic deficiency in nucleoside transport with respect to ddC toxicity and ddC incorporation. These data indicate that the intracellular metabolism of ddC in CEM cells is initiated by the nucleoside transport system and deoxycytidine kinase and has important implications for the design of biochemically rational chemotherapeutic regimens exploiting antiretroviral nucleoside analogs in the treatment of AIDS. receptor sites, and 100 uM dipyridamole, a ligand for uptake sites, decreased binding by, respectively, 39 and 33 %.
In contrast, neither S-Ado nor SAICAriboside, both at up to 200 11 M concentrations, influenced the binding of 12-3111~do. These results indicate that the psychomotor defects observed in ASase deficiency are probably not due to the occupation of cortical membrane sites for Ado by the succinylpurines.
